Difference between revisions of "Team:New York City/HD"

Line 1: Line 1:
−
<!doctype html>
 
 
<html lang="en">
 
<html lang="en">
 
<head>
 
<head>
Line 10: Line 9:
 
         a{
 
         a{
 
             color:#7B84ED;
 
             color:#7B84ED;
 +
        }
 +
        p{
 +
            font-size: 120%;
 
         }
 
         }
 
         .shiny{
 
         .shiny{
Line 31: Line 33:
 
                         </a>
 
                         </a>
 
                         <div class="dropdown-menu" aria-labelledby="navbarPR">
 
                         <div class="dropdown-menu" aria-labelledby="navbarPR">
−
                             <a class="dropdown-item" href="https://2018.igem.org/Team:New_York_City/HD/">What is HD?</a>
+
                             <a class="dropdown-item" href="https://2018.igem.org/Team:New_York_City/HD">What is HD?</a>
 
                             <a class="dropdown-item" href="">Coming Soon</a>
 
                             <a class="dropdown-item" href="">Coming Soon</a>
 
                         </div>
 
                         </div>
Line 65: Line 67:
  
 
<div class="container">
 
<div class="container">
−
     <p clas="lead">Huntington's disease (HD) is an inherited, autosomal dominant disorder that causes the progressive degeneration
+
     <p class="lead">Huntington's disease (HD) is an inherited, autosomal dominant disorder that causes the progressive degeneration
 
         of nerve cells in the basal ganglia, a part of the brain that is responsible for coordination and movement. It
 
         of nerve cells in the basal ganglia, a part of the brain that is responsible for coordination and movement. It
 
         is caused by a trinucleotide repeat of 40 or more CAG codons in the huntingtin protein. The exact function of
 
         is caused by a trinucleotide repeat of 40 or more CAG codons in the huntingtin protein. The exact function of
Line 81: Line 83:
 
         <li>Involuntary movement and loss of physical coordination</li>
 
         <li>Involuntary movement and loss of physical coordination</li>
 
     </ul>
 
     </ul>
−
     <p>HD is adult-onset, usually affecting people in between their 30's to 50's. Symptoms typically worsen over a
+
    <br/>
 +
     <p class="lead">HD is adult-onset, usually affecting people in between their 30's to 50's. Symptoms typically worsen over a
 
         10 to 25 year period and greatly impact both mental and physical abilities. Eventually, they pass away due
 
         10 to 25 year period and greatly impact both mental and physical abilities. Eventually, they pass away due
 
         to heart failure or other complications.</p>
 
         to heart failure or other complications.</p>
Line 91: Line 94:
  
 
<div class="container">
 
<div class="container">
−
     <p>Huntington's disease affects all people regardless of their gender or ethnicity; however, some group is more
+
     <p class="lead">Huntington's disease affects all people regardless of their gender or ethnicity; however, some group is more
 
         prone to the disease than others are. It occurs more frequently among people with European origin than among
 
         prone to the disease than others are. It occurs more frequently among people with European origin than among
 
         any other population. In the United States, around 30,000 people are diagnosed with Huntington's disease. This
 
         any other population. In the United States, around 30,000 people are diagnosed with Huntington's disease. This
Line 104: Line 107:
  
 
<div class="container">
 
<div class="container">
−
     <p>Currently, the complications of Huntington's disease can be mitigated by medication for movement disorders and
+
     <p class="lead">Currently, the complications of Huntington's disease can be mitigated by medication for movement disorders and
 
         psychiatric disorders (such as antidepressants), along with psychotherapy, speech therapy, physical therapy,
 
         psychiatric disorders (such as antidepressants), along with psychotherapy, speech therapy, physical therapy,
 
         and occupational therapy. However, there exists no treatment to completely cure or slow the development of HD,
 
         and occupational therapy. However, there exists no treatment to completely cure or slow the development of HD,
 
         although there has been ongoing research and experimental therapies.</p>
 
         although there has been ongoing research and experimental therapies.</p>
−
     <p>Our goal is to employ genetics to find an efficient resolution for HD, hence our name:
+
     <p class="lead">Our goal is to employ genetics to find an efficient resolution for HD, hence our name:
 
         <span class="shiny"><strong>HD Resolution</strong></span></p>
 
         <span class="shiny"><strong>HD Resolution</strong></span></p>
 
</div>
 
</div>
  
 
<div class="container">
 
<div class="container">
−
     <p>Sources:</p>
+
     <p class="lead">Sources:</p>
 
     <ol>
 
     <ol>
 
         <li><a href="http://hdsa.org/what-is-hd/">hdsa.org</a></li>
 
         <li><a href="http://hdsa.org/what-is-hd/">hdsa.org</a></li>
Line 122: Line 125:
 
<script src="https://stackpath.bootstrapcdn.com/bootstrap/4.1.3/js/bootstrap.min.js" integrity="sha384-ChfqqxuZUCnJSK3+MXmPNIyE6ZbWh2IMqE241rYiqJxyMiZ6OW/JmZQ5stwEULTy" crossorigin="anonymous"></script>
 
<script src="https://stackpath.bootstrapcdn.com/bootstrap/4.1.3/js/bootstrap.min.js" integrity="sha384-ChfqqxuZUCnJSK3+MXmPNIyE6ZbWh2IMqE241rYiqJxyMiZ6OW/JmZQ5stwEULTy" crossorigin="anonymous"></script>
 
</body>
 
</body>
 +
</html>

Revision as of 07:11, 31 August 2018

What is Huntington's Disease?

Huntington's disease (HD) is an inherited, autosomal dominant disorder that causes the progressive degeneration of nerve cells in the basal ganglia, a part of the brain that is responsible for coordination and movement. It is caused by a trinucleotide repeat of 40 or more CAG codons in the huntingtin protein. The exact function of the huntingtin protein is unknown but it is critical in nerve cell function. Thus, there is a wide range of symptoms and signs from cognitive, movement, and psychiatric disorders such as:

  • Muscle problems, such as contraction or rigidity
  • Abnormal eye movements
  • Difficulty processing information
  • Fatigue, loss of energy
  • Social withdrawal
  • Mood swings and depression
  • Amnesia and handicapped judgement
  • Impaired speaking abilities and significant weight loss
  • Involuntary movement and loss of physical coordination

HD is adult-onset, usually affecting people in between their 30's to 50's. Symptoms typically worsen over a 10 to 25 year period and greatly impact both mental and physical abilities. Eventually, they pass away due to heart failure or other complications.

Who is affected by Huntington's Disease?

Huntington's disease affects all people regardless of their gender or ethnicity; however, some group is more prone to the disease than others are. It occurs more frequently among people with European origin than among any other population. In the United States, around 30,000 people are diagnosed with Huntington's disease. This is only a small percentage of the US population, but it has the potential to grow quickly. 200,000 people are at risk of inheriting HD, as the child of an affected parent has a 50-50% chance of having a gene that causes the disease.

Is There a Cure?

Currently, the complications of Huntington's disease can be mitigated by medication for movement disorders and psychiatric disorders (such as antidepressants), along with psychotherapy, speech therapy, physical therapy, and occupational therapy. However, there exists no treatment to completely cure or slow the development of HD, although there has been ongoing research and experimental therapies.

Our goal is to employ genetics to find an efficient resolution for HD, hence our name: HD Resolution

Sources:

  1. hdsa.org